133 related articles for article (PubMed ID: 25354045)
1. Acromegaly and bone disease.
Anthony JR; Ioachimescu AG
Curr Opin Endocrinol Diabetes Obes; 2014 Dec; 21(6):476-82. PubMed ID: 25354045
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of morphometric vertebral fractures in "difficult" patients with acromegaly with different biochemical outcomes after multimodal treatment.
Chiloiro S; Mormando M; Bianchi A; Giampietro A; Milardi D; Bima C; Grande G; Formenti AM; Mazziotti G; Pontecorvi A; Giustina A; De Marinis L
Endocrine; 2018 Feb; 59(2):449-453. PubMed ID: 28836162
[TBL] [Abstract][Full Text] [Related]
3. Progression of vertebral fractures despite long-term biochemical control of acromegaly: a prospective follow-up study.
Claessen KM; Kroon HM; Pereira AM; Appelman-Dijkstra NM; Verstegen MJ; Kloppenburg M; Hamdy NA; Biermasz NR
J Clin Endocrinol Metab; 2013 Dec; 98(12):4808-15. PubMed ID: 24081732
[TBL] [Abstract][Full Text] [Related]
4. Influence of diabetes mellitus on vertebral fractures in men with acromegaly.
Mazziotti G; Gola M; Bianchi A; Porcelli T; Giampietro A; Cimino V; Doga M; Gazzaruso C; De Marinis L; Giustina A
Endocrine; 2011 Aug; 40(1):102-8. PubMed ID: 21594681
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of vertebral fractures in men with acromegaly.
Mazziotti G; Bianchi A; Bonadonna S; Cimino V; Patelli I; Fusco A; Pontecorvi A; De Marinis L; Giustina A
J Clin Endocrinol Metab; 2008 Dec; 93(12):4649-55. PubMed ID: 18827004
[TBL] [Abstract][Full Text] [Related]
6. Acromegaly versus hypogonadism: Bone fragility and evaluation.
Sorohan MC; Baciu IF; Galoiu SA; Niculescu DA; Caragheorgheopol A; Iordachescu CN; Poiana C
Ann Endocrinol (Paris); 2023 Dec; 84(6):719-726. PubMed ID: 37689348
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of vertebral fractures and serum sclerostin levels in acromegaly.
Uygur MM; Yazıcı DD; Buğdaycı O; Yavuz DG
Endocrine; 2021 Sep; 73(3):667-673. PubMed ID: 34019235
[TBL] [Abstract][Full Text] [Related]
8. Quantitative computed tomography of the lumbar spine, not dual x-ray absorptiometry, is an independent predictor of prevalent vertebral fractures in postmenopausal women with osteopenia receiving long-term glucocorticoid and hormone-replacement therapy.
Rehman Q; Lang T; Modin G; Lane NE
Arthritis Rheum; 2002 May; 46(5):1292-7. PubMed ID: 12115236
[TBL] [Abstract][Full Text] [Related]
9. Hip bone mineral density, bone turnover and risk of fracture in patients on long-term suppressive L-thyroxine therapy for differentiated thyroid carcinoma.
Heijckmann AC; Huijberts MS; Geusens P; de Vries J; Menheere PP; Wolffenbuttel BH
Eur J Endocrinol; 2005 Jul; 153(1):23-9. PubMed ID: 15994742
[TBL] [Abstract][Full Text] [Related]
10. Higher prevalence of morphometric vertebral fractures in patients with recent coronary events independently of BMD measurements.
Silva HC; Pinheiro MM; Genaro PS; Castro CH; Monteiro CM; Fonseca FA; Szejnfeld VL
Bone; 2013 Feb; 52(2):562-7. PubMed ID: 23142805
[TBL] [Abstract][Full Text] [Related]
11. High prevalence of asymptomatic vertebral fractures in post-menopausal women receiving chronic glucocorticoid therapy: a cross-sectional outpatient study.
Angeli A; Guglielmi G; Dovio A; Capelli G; de Feo D; Giannini S; Giorgino R; Moro L; Giustina A
Bone; 2006 Aug; 39(2):253-9. PubMed ID: 16574519
[TBL] [Abstract][Full Text] [Related]
12. Vertebral fractures in patients with acromegaly: a 3-year prospective study.
Mazziotti G; Bianchi A; Porcelli T; Mormando M; Maffezzoni F; Cristiano A; Giampietro A; De Marinis L; Giustina A
J Clin Endocrinol Metab; 2013 Aug; 98(8):3402-10. PubMed ID: 23771918
[TBL] [Abstract][Full Text] [Related]
13. Vertebral fracture assessment in acromegaly.
Madeira M; Neto LV; Torres CH; de Mendonça LM; Gadelha MR; de Farias ML
J Clin Densitom; 2013; 16(2):238-43. PubMed ID: 22884713
[TBL] [Abstract][Full Text] [Related]
14. The degree of osteoporosis in patients with vertebral fracture and patients with hip fracture: relationship to incidence of vertebral fracture.
Takahashi M; Kushida K; Naitou K
J Bone Miner Metab; 1999; 17(3):187-94. PubMed ID: 10757678
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of osteoporosis and vertebral fractures in postmenopausal women with type 2 diabetes mellitus and their relationship with duration of the disease and chronic complications.
Viégas M; Costa C; Lopes A; Griz L; Medeiro MA; Bandeira F
J Diabetes Complications; 2011; 25(4):216-21. PubMed ID: 21458300
[TBL] [Abstract][Full Text] [Related]
16. Acromegaly is associated with vertebral deformations but not vertebral fractures: Results of a cross-sectional monocentric study.
Plard C; Hochman C; Hadjadj S; Le Goff B; Maugars Y; Cariou B; Drui D; Guillot P
Joint Bone Spine; 2020 Dec; 87(6):618-624. PubMed ID: 32428690
[TBL] [Abstract][Full Text] [Related]
17. High prevalence of vertebral fractures despite normal bone mineral density in patients with long-term controlled acromegaly.
Wassenaar MJ; Biermasz NR; Hamdy NA; Zillikens MC; van Meurs JB; Rivadeneira F; Hofman A; Uitterlinden AG; Stokkel MP; Roelfsema F; Kloppenburg M; Kroon HM; Romijn JA; Pereira AM
Eur J Endocrinol; 2011 Apr; 164(4):475-83. PubMed ID: 21257726
[TBL] [Abstract][Full Text] [Related]
18. Vertebral deformity in the thoracic spine in post-menopausal women: value of lumbar spine bone density.
Grey C; Young R; Bearcroft PW; Compston JE
Br J Radiol; 1996 Feb; 69(818):137-42. PubMed ID: 8785641
[TBL] [Abstract][Full Text] [Related]
19. Postmenopausal Canarian women receiving oral glucocorticoids have an increased prevalence of vertebral fractures and low values of bone mineral density measured by quantitative computer tomography and dual X-ray absorptiometry, without significant changes in parathyroid hormone.
Sosa M; Jódar E; Saavedra P; Navarro MC; Gómez de Tejada MJ; Martín A; Peña P; Gómez J
Eur J Intern Med; 2008 Jan; 19(1):51-6. PubMed ID: 18206602
[TBL] [Abstract][Full Text] [Related]
20. Additional beneficial effects of alendronate in growth hormone (GH)-deficient adults with osteoporosis receiving long-term recombinant human GH replacement therapy: a randomized controlled trial.
Biermasz NR; Hamdy NA; Janssen YJ; Roelfsema F
J Clin Endocrinol Metab; 2001 Jul; 86(7):3079-85. PubMed ID: 11443170
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
